Invasix develops manufactures and sells semi-invasive and non-invasive products for aesthetic surgery. The company’s proprietary technology enables physicians to broaden their offering to potential patients, and deliver better results in shorter and simpler procedures.
Investors 1
| Date | Name | Website |
| - | Israel Hea... | ihcv.co.il... |
Mentions in press and media 2
| Date | Title | Description |
| 12.10.2021 | InMode : Expects Record Third Quarter 2021 Revenue of $93.5M-$94M, Raising Full-Year 2021 Revenue Guidance to $343M-$347M | YOKNEAM, Israel, Oct. 12, 2021 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technologies, announced today that it expects to release its financial results for the third quarter of 2021 before t... |
| 12.01.2021 | InMode Expects Record Fourth Quarter and Full Year 2020 Results, Fourth Quarter Revenue Between $74.5-$75M, Non-GAAP Earnings per Diluted Share Between $0.91-$0.93; Announces 2021 Full Year Revenue Gu... |